● Wnt/Beta-catenin inhibitors block replication of SARS-CoV2, other coronaviruses and pathogenic RNA viruses
● Potential to repurpose existing compounds
Researchers from the University of Alberta Department of Cell Biology have identified a novel class of small molecules with antiviral activity. Using multiple human primary cell types and cell lines, we have demonstrated in vitro that Wnt/Beta-catenin inhibitors block replication of SARS-CoV2 when administered pre- and post- infection. Some Wnt/Beta-catenin inhibitors were shown to significantly reduce SARS-CoV2 viral titres in normal bronchial epithelial lung cells. Certain Wnt/beta-catenin inhibitors demonstrated efficacy against HCOV-229E, HCOV-NL63, Zika virus and Mayoro virus.
Wnt/Beta-catenin inhibitors may achieve this effect through inducing peroxisome proliferation and enhancing interferon production; interferon production is not induced by these compounds in the absence of viral infection.
Intellectual property status
Patent already applied for
Patent application number : WO2022020967
Where : PCT
Transforming discoveries and innovations into reality is a complex and lengthy process. UAlberta’s Technology Transfer Services (TTS) team helps facilitate this journey. Part of the Vice-President (Research and Innovation) portfolio, TTS helps researchers, postdoctoral fellows, staff and students transform innovations and discoveries into reality—moving them out of the university to benefit society, the economy, the world.
Create your free account to connect with University of Alberta, Technology Transfer Services and thousands of other innovative organizations and professionals worldwide
Send a request for information
to University of Alberta, Technology Transfer Services
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
